Attached files
| file | filename |
|---|---|
| EX-4.2 - EX-4.2 - Aclaris Therapeutics, Inc. | acrs-20201231xex4d2.htm |
| EX-10.12 - EX-10.12 - Aclaris Therapeutics, Inc. | acrs-20201231xex10d12.htm |
| EX-10.16 - EX-10.16 - Aclaris Therapeutics, Inc. | acrs-20201231xex10d16.htm |
| EX-23.1 - EX-23.1 - Aclaris Therapeutics, Inc. | acrs-20201231xex23d1.htm |
| EX-31.1 - EX-31.1 - Aclaris Therapeutics, Inc. | acrs-20201231xex31d1.htm |
| EX-31.2 - EX-31.2 - Aclaris Therapeutics, Inc. | acrs-20201231xex31d2.htm |
| EX-32.1 - EX-32.1 - Aclaris Therapeutics, Inc. | acrs-20201231xex32d1.htm |
| 10-K - 10-K - Aclaris Therapeutics, Inc. | acrs-20201231x10k.htm |
Exhibit 21.1
Subsidiaries of Aclaris Therapeutics, Inc.
Name of Subsidiary |
| Jurisdiction of Incorporation or |
|
|
|
Aclaris Therapeutics International Limited |
| United Kingdom |
Aclaris Life Sciences, Inc. |
| Delaware |
Confluence Discovery Technologies, Inc. | | Delaware |